IP Library Granted Patent US 8,430,919
Granted Patent B2
US 8,430,919 · App. 13/182,284 · Granted Apr 30, 2013

Optical method and device for modulation of biochemical processes in adipose tissue

Inventor: Eric Bornstein (Brooklyn, NY)
Assignee: Nomir Medical Technologies, Inc.
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 8,430,919
App. No.
13/182,284
Granted
Apr 30, 2013
Kind
B2
Abstract

Optical methods and devices are provided for the reduction of the lipid content of adipocytes without significant heat or intolerable adverse effect on the cells and their surrounding tissues. The optical method and device can be used to irradiate adipose tissue through the skin with non-thermal and non-destructive effects by application of near infrared (NIR) irradiation at selected wave bands in selected ranges to affect modulation of innate enzymatic processes involved in lipolysis, lipogenesis, leptin secretion, adiponectin secretion, and/or glucose absorption.

Claims (30)

1. A method of reducing lipid level in an adipocyte, without generating significant heat in, or significant damage to the adipocyte, comprising the steps of:

irradiating a target site on an individual's skin above adipose tissue with optical radiation having wavelengths in the range of 925 nm to 935 nm at a dosimetry from 0.015 W/cm^2 to 1.0 W/cm^2; and

directing the optical radiation to the target site with a top hat distribution having a spot size with an area of at least 1.13 cm^2.

2. The method according to claim 1 , further comprising initiating at least one adipocyte biochemical processes with exercise immediately before or simultaneous with the irradiation.

3. The method according to claim 1 , wherein at least one of the biochemical processes of adipocytes is selected from lipolysis, and leptin production.

4. The method according to claim 1 , further comprising initiating at least one biochemical processes with exercise simultaneous with the irradiation.

5. The method according to claim 1 , wherein the optical radiation is provided for a time of from 10 to 120 minutes.

6. The method according to claim 1 , wherein the optical radiation is provided for a time of from 15 to 100 minutes.

7. The method according to claim 1 , wherein the optical radiation is provided for a time of from 20 to 80 minutes.

8. The method according to claim 1 , wherein the dosimetry provides an energy density from 10 J/cm^2 to 10,000 J/^2 at the skin surface above the adipose tissue.

9. The method according to claim 1 , wherein the dosimetry provides an energy density from 50 J/cm^2 to 8,000 J/^2 at the skin surface above the adipose tissue.

10. The method according to claim 1 , wherein the dosimetry provides an energy density from 100 J/cm^ 2 to 5,000 J/^2 at the skin surface above the adipose tissue.

11. The method according to claim 1 , further comprising delivering the optical radiation to the target site by one or more LEDs or LED arrays with aspheric collimating lenses within an article of clothing or a wrap.

12. The method according to claim 1 , comprising causing biochemical processes within the adipocytes that are normally antagonistic to each other to function synergistically.

13. A device for reducing fat comprising:

at least one light source configured to irradiate a target site on an individual's skin above adipose tissue with optical radiation having wavelengths in the range of 925 nm to 935 nm at a dosimetry from 0.015 W/cm^2 to 1.0 W/cm^2 to modulate at least one of the innate biochemical processes of adipocytes; and

an optical delivery device configured to direct the optical radiation to the target site with a top hat distribution having a spot size with an area of at least 1.13 cm^2;

wherein said at least one light source is attached to an item of clothing.

14. The device according to claim 13 , wherein it is incorporated into a piece of an exercise equipment or other apparatus as an accessory item.

15. The device according to claim 13 , the optical radiation has a wavelength from 925 nm to 935 nm.

16. The device according to claim 13 , further comprising a controller adapted to control said optical radiation to provide a succession of radiation pulses.

17. The device according to claim 16 , wherein the controller is further adapted to control the intensity of said radiation pulses.

18. The device according to claim 16 , wherein the controller is adapted to control the repetition rate of said radiation pulses.

19. The method according to claim 1 , comprising modulating at least one of the innate biochemical processes to stimulate leptin production.

20. The method according to claim 2 , comprising accelerating exercise initiated biochemical lipolysis through optically mediated mechano-transduction.

21. The method according to claim 1 , comprising accelerating pharmacologically initiated biochemical lipolysis through optically mediated mechano-transduction.

22. A method comprising:

increasing leptin production in an adipocyte without generating significant heat in, or significant damage to the adipocyte, the step of increasing leptin comprising:

irradiating a target site on an individual's skin above adipose tissue with optical radiation having wavelengths in the range of 925 nm to 935 nm at a dosimetry from 0.015 W/cm^2 to 1.0 W/cm^2; and

directing the optical radiation to the target site with a top hat distribution having a spot size with an area of at least 1.13 cm^2.

Assignments (2)
SECURITY INTEREST Recorded Nov 24, 2015
From: NOMIR MEDICAL TECHNOLOGIES, INC.
To: GOODKIN AS AGENT FOR VARIOUS NOTE HOLDERS, RICHARD P.
Reel/Frame 037131/0811 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Mar 29, 2013
From: BORNSTEIN, ERIC
To: NOMIR MEDICAL TECHNOLOGIES, INC.
Reel/Frame 030119/0036 →
Continuity (4)
Continuation 11657809 · Jan 24, 2007
Provisional Application 60761717 · Jan 24, 2006
Provisional Application 60781260 · Mar 9, 2006
Related Publication 20120116484A1 · May 10, 2012